Journal of Neural Transmission

Papers
(The TQCC of Journal of Neural Transmission is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Ried47
Recent update on the heterogeneity of the Alzheimer’s disease spectrum44
Dystonia updates: definition, nomenclature, clinical classification, and etiology40
Effects of safinamide on pain in Parkinson’s disease with motor fluctuations: an exploratory study39
Impact of the COVID-19 lockdown on screen media use in patients referred for ADHD to child and adolescent psychiatry: an introduction to problematic use of the internet in ADHD and results of a survey38
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease36
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity36
Neuropathological assessment of the Alzheimer spectrum35
Contemporary functional neuroanatomy and pathophysiology of dystonia34
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials34
Do not keep it simple: recent advances in the generation of complex organoids32
Neuronal intranuclear inclusion disease: recognition and update29
Emerging and converging molecular mechanisms in dystonia29
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration27
Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease26
A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease26
ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning25
Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis25
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice24
A brief history of brain iron accumulation in Parkinson disease and related disorders23
Viruses, parkinsonism and Parkinson’s disease: the past, present and future23
Hypothyroidism after radiation exposure: brief narrative review22
COVID-19 outcomes of 10,881 patients: retrospective study of neurological symptoms and associated manifestations (Philippine CORONA Study)22
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t22
GBA-associated PD: chances and obstacles for targeted treatment strategies22
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia22
Language in autism: domains, profiles and co-occurring conditions21
Glucocerebrosidase mutations and Parkinson disease21
Mental health dished up—the use of iPSC models in neuropsychiatric research20
Improvement of brain functional connectivity in autism spectrum disorder: an exploratory study on the potential use of virtual reality20
Chorea in children: etiology, diagnostic approach and management20
Metacognition in adult ADHD: subjective and objective perspectives on self-awareness of cognitive functioning19
Neurorehabilitation in dystonia: a holistic perspective19
Glucocerebrosidase (GBA) gene variants in a multi-ethnic Asian cohort with Parkinson’s disease: mutational spectrum and clinical features19
Safinamide improves executive functions in fluctuating Parkinson’s disease patients: an exploratory study19
Neuropsychological functioning of individuals at clinical evaluation of adult ADHD19
Parkinson and depression: review and outlook19
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan19
Morphological basis of Parkinson disease-associated cognitive impairment: an update19
Feigning ADHD and stimulant misuse among Dutch university students19
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease19
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview18
Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson’s disease18
Cerebral white matter changes in deficit and non-deficit subtypes of schizophrenia18
Neurodegenerative proteinopathies associated with neuroinfections18
Genes and hormones of the hypothalamic–pituitary–adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?18
Cognitive characterization of adult attention deficit hyperactivity disorder by domains: a systematic review17
Autoimmune encephalitis with psychiatric features in adults: historical evolution and prospective challenge17
Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis17
The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models17
Isolated dystonia: clinical and genetic updates17
SIRT1 and SIRT2 modulators reduce LPS-induced inflammation in HAPI microglial cells and protect SH-SY5Y neuronal cells in vitro17
The cerebral blood flow deficits in Parkinson’s disease with mild cognitive impairment using arterial spin labeling MRI16
Recent trends in mental illness and omega-3 fatty acids16
The pathobiological basis of depression in Parkinson disease: challenges and outlooks15
Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis15
The MPTP-lesioned marmoset model of Parkinson’s disease: proposed efficacy thresholds that may potentially predict successful clinical trial results15
Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease14
Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients14
Botulinum toxin therapy of dystonia14
Evaluation for Parkinsonian Bradykinesia by deep learning modeling of kinematic parameters14
Protein clearance strategies for disease intervention14
Emergent creativity in frontotemporal dementia14
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses14
Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort13
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network13
Neuropathological findings in multiple system atrophy with cognitive impairment13
Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases13
The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease13
Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors13
The heterogeneity of Parkinson’s disease13
Endocannabinoid levels in patients with Parkinson’s disease with and without levodopa-induced dyskinesias13
Repetitive transcranial magnetic stimulation in the treatment of resistant depression: changes of specific neurotransmitter precursor amino acids13
Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach13
Beyond tics: movement disorders in patients with Tourette syndrome13
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort12
Hemispheric asymmetries in mental disorders: evidence from rodent studies12
Comparison of the rate of dedifferentiation with increasing passages among cell sources for an in vitro model of the blood–brain barrier12
Dopamine transporter (DAT) imaging in Parkinson’s disease and related disorders12
Combined dystonias: clinical and genetic updates12
ADHD and offending12
Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients12
Disease-modifying treatment of Parkinson’s disease by phytochemicals: targeting multiple pathogenic factors12
Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study11
Complex dystonias: an update on diagnosis and care11
Is the vertex a good control stimulation site? Theta burst stimulation in healthy controls11
Current experimental disease-modifying therapeutics for multiple system atrophy11
Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia11
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS)11
Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress11
Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update11
Autism Spectrum Disorder and auditory sensory alterations: a systematic review on the integrity of cognitive and neuronal functions related to auditory processing11
Plasma neurofilament light chain level and orthostatic hypotension in early Parkinson’s disease11
Interleukin-6 secretion upon acute psychosocial stress as a potential predictor of psychotherapy outcome in posttraumatic stress disorder11
Long-term effects of chronic stress models in adult mice11
Effects of head trauma and sport participation in young-onset Parkinson’s disease11
Resident CD34-positive cells contribute to peri-endothelial cells and vascular morphogenesis in salivary gland after irradiation11
Normal pressure hydrocephalus and CSF tap test response: the gait phenotype matters10
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey10
Anxiety, depression and psychosocial needs are the most frequent concerns reported by patients: preliminary results of a comparative explorative analysis of two hospital-based palliative care teams in10
Stress and pain: modality-specific opioid mediation of stress-induced analgesia10
Internet-based cognitive behavioral therapy in children and adolescents with obsessive compulsive disorder: a feasibility study10
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor10
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes10
Effect of the mGlu2 positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset10
Serum neurofilament light chain and postural instability/gait difficulty (PIGD) subtypes of Parkinson’s disease in the MARK-PD study10
Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease10
Synaptic plasticity mechanisms behind TMS efficacy: insights from its application to animal models10
Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease10
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 201710
Life style and Parkinson’s disease10
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment10
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles10
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue9
Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients9
Botulinum toxin therapy: past, present and future developments9
Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study9
Associations of age, sex, sexual abuse, and genotype with monoamine oxidase a gene methylation9
Gaze behavior is associated with the cortisol response to acute psychosocial stress in the virtual TSST9
The relationship of early- and late-onset Alzheimer’s disease genes with COVID-199
Implications of dopaminergic medication withdrawal in Parkinson’s disease9
Essential tremor plus rest tremor: current concepts and controversies9
Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly9
Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson’s disease9
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated multiple sclerosis syndrome9
Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies9
Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer’s disease9
C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy9
The heterogeneity of late-life depression and its pathobiology: a brain network dysfunction disorder9
NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity9
Blood neurofilament light chain in Parkinson’s disease9
Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales9
α7 nicotinic receptors contributes to glutamatergic activity in the hippocampus of patients with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS)9
Voxel-based lesion symptom mapping analysis for dysphagia in stroke patients with isolated cerebellar lesions9
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes9
Endocannabinoid and dopaminergic system: the pas de deux underlying human motivation and behaviors9
Genetic updates on paroxysmal dyskinesias8
Association of early and later depressive symptoms with functional outcome after ischemic stroke8
Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients8
Depression in dementia with Lewy bodies: a critical update8
Cholinergic brain network deficits associated with vestibular sensory conflict deficits in Parkinson’s disease: correlation with postural and gait deficits8
Autophagy in trimethyltin-induced neurodegeneration8
X-linked dystonia Parkinsonism: crossing a new threshold8
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models8
Suboptimal response to STN-DBS in Parkinson’s disease can be identified via reaction times in a motor cognitive paradigm8
Associations between age and cortisol awakening response in patients with borderline personality disorder8
0.0906081199646